A newly-developed preference assessment tool successfully captured patients' goals, values, and preferences for multiple sclerosis (MS) treatment and could potentially be used to help patients communicate their preferences to their clinician, according to a recent investigation. Patients with MS between the ages of 21 and 75 who had access to the Internet (n=135) were recruited. They completed the preference tool online, which included separate modules assessing 3 core preference areas: treatment goals, preferences for attributes of disease-modifying therapies (DMTs), and factors influencing a change in treatment. Immediately after viewing a summary of their treatment goals and preferences, participants were asked to evaluate the tool. Rankings of preference domains were compared to rankings obtained in another study. Investigators found:
- The highest ranked goals were brain health (memory, thinking, and brain), followed by disability concerns (walking, strength, vision).
- Rankings were highly similar to those in the referent study.
- Nearly all participants reported that the tool helped them understand their goals and priorities regarding MS and that the summary appropriately reflected what is important to them.
- Most (87%) expressed a desire to discuss their treatment goals and priorities with their clinician.
Col NF, Solomon AJ, Springmann V, et al. Evaluation of a novel preference assessment tool for patients with multiple sclerosis. [Published online ahead of print January 25, 2018]. Int J MS Care. doi:10.7224/1537-2073.2017-021.
This Week's Must Reads
Vegetable/Fruit Intake Benefits Cognitive Function, Neurology; ePub 2018 Nov 21; Yuan, Fondell, et al
Alzheimer Dementia and Age-Related Neuropathologies, Ann Neurol; ePub 2018 Nov 12; Boyle, Yu, et al
Kidney Function and Post-Stroke Mortality Examined, Stroke; ePub 2018 Nov 9; El Husseini, Fonarow, et al
Meditation May Help to Alleviate US Stroke Burden, J Stroke Cerebrovasc Dis; ePub 2018 Nov 24; Ambavane, et al
FDA Approves Firdapse for Rare Autoimmune Disorder, FDA news release; 2018 Nov 28
Must Reads in Multiple Sclerosis
Exposure to Animals Associated with Risk of MS, Mult Scler Relat Disord; ePub 2018 Nov 15; de Jong, et al
White Matter Tract Disruption, Fatigue Examined, Mult Scler Relat Disord; ePub 2018 Nov 9; Fuchs, et al
Coexistence of Multiple Sclerosis, Alzheimer Disease, Mult Scler Relat Disord; ePub 2018 Oct 27; Luczynski, et al
Body Mass Index Linked with Brain Volume Change, Neurology; ePub 2018 Nov 14; Mowry, Azevedo, et al
Detection of Whole Brain, Deep GM Atrophy in MS, PLoS One; ePub 2018 Nov 8; Chu, Kim, et al